Monkeypox Virus: Transmission, Signs and Symptoms, Prevention, and Epidemiology



Abstract Views
268

Downloads
184

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Jul 13, 2022
Published Oct 19, 2022
10.24018/ejmed.2022.4.5.1422

Abstract viewed = 268 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Monkeypox virus causes a zoonotic disease that is similar to smallpox-like illness. This review focuses on the overall epidemiology of monkeypox infection along with the transmission, signs and symptoms, treatment and prevention of the infection among humans. The early symptoms of the infection are flu-like and include fever, malaise, headache, papulopustular rash, sore throat and enlarged lymph nodes. Previously, it was reported in African countries only, with majority of the reported cases in Democratic Republic of Congo (DRC). Later in 2003, the first case of monkeypox infection was reported outside Africa in the U.S. with additional cases in the UK, Israel and Singapore. The transmission of monkeypox virus occurs primarily from animal to human and secondarily from human to human by contact with respiratory secretions or lesions of infected persons. Moreover, monkeypox virus can also be transmitted sexually from male to male and results in rashes and lesions around the genital or anal area of the infected person. Currently, there is no specific treatment for monkeypox infection. However, anti-viral treatment for smallpox, cytomegalovirus retinitis in AIDS patients, and the vaccine vaccinia virus intravenous immunoglobulins are the choice of therapeutics for treating the infection. This review focuses on the overall epidemiology of monkeypox infection along with the transmission, signs and symptoms, treatment and prevention of the infection among humans.

Keywords: Anti-viral Treatment, Central-African Clade, Cidofovir and Vaccinia Immune Globulin Intravenous, Cidofovir Therapy, Cidofovir Treatment, Congo Basin Clade, Epidemiology of Mnkeypox, Imvamune Vaccine, Imvanex Vaccine, JYNNEOS, Monkeypox, Orthopoxvirus, Pox-Like Diseases, Poxviridae, Sexually-Transmitted Diseases, Smallpox-Like Diseases, STD, Sexually-transmitted Infection, STI, Tecovirimat, Varioloa, VIGIV, Viral Exanthema, West-African Clade, Zoonotic Disease

Downloads

Download data is not yet available.

References

  1. reman JG. Monkeypox: an emerging infection for humans?. Emerging Infections 4. 2000: 45-67.
    DOI  |   Google Scholar
  2. Reynolds MG, Yorita KL, Kuehnert MJ, Davidson WB, Huhn GD, Holman RC, et al. Clinical manifestations of human monkeypox influenced by route of infection. Journal of Infectious Diseases. 2
     Google Scholar
  3. Bartlett JG. The detection of monkeypox in humans in the western hemisphere. Infectious Diseases in Clinical Practice. 2004; 12(4): 275–276.
     Google Scholar
  4. Chen N, Li G, Liszewski MK, Atkinson JP, Jahrling PB, Feng Z, et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology. 2005; 340(1): 46–63.
    DOI  |   Google Scholar
  5. Sbrana E, Xiao S.-Y, Newman PC, Tesh RB. Comparative pathology of North American and central African strains of monkeypox virus in a ground squirrel model of the disease. The American Journal of Tropical Medicine and Hygiene. 2007; 76(1): 155–164.
    DOI  |   Google Scholar
  6. Shchelkunov SN, Totmenin AV, Babkin IV, Safronov PF, Ryazankina OI, Petrov NA, et al. Human monkeypox and smallpox viruses: Genomic comparison. FEBS Letters. 2001; 509(1): 66–70.
    DOI  |   Google Scholar
  7. World Health Organization. World Health Organization. [Internet] 2022 Monkeypox. [cited 2022 June 15] Available from: from https://www.who.int/news-room/fact-sheets/detail/monkeypox
     Google Scholar
  8. Nolen LD, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, Doty, J., et al. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo. Emerging Infectious Diseases. 2016; 22(6): 1014–1021.
    DOI  |   Google Scholar
  9. World Health Organization. Monkeypox: Public Health Advice for gay, bisexual and other men who have sex with men. World Health Organization. [Internet] 2022 Monkeypox. [cited 2022 June 16] Available from: from https://www.who.int/news/item/25-05-2022- monkeypox--public-health-advice-for-gay--bisexual-and-other-men-who-have-sex-with-men
     Google Scholar
  10. Sklenovská N, Van Ranst M. Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Frontiers in Public Health. 2008; 6(September): 1–12.
    DOI  |   Google Scholar
  11. FDA. Jynneos. U.S. Food and Drug Administration. [Internet] 2021 [cited 2022 June 16] Available from: https://www.fda.gov/vaccines-blood-biologics/jynneos
     Google Scholar
  12. Cono J, Cragan JD, Jamieson DJ, Rasmussen SA. Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerging Infectious Diseases. 2006; 12(11): 1631–1637.
    DOI  |   Google Scholar
  13. Mbala PK, Huggins JW, Riu-Rovira T, Ahuka SM, Mulembakani P, Rimoin AW, et al. Maternal and Fetal Outcomes among Pregnant Women with Human Monkeypox Infection in the Democratic Republic of Congo. Journal of Infectious Diseases. 2017; 216(7): 824–828.
    DOI  |   Google Scholar
  14. Ogoina D, Iroezindu M, James HI, Oladokun R, Yinka-Ogunleye A, Wakama P, et al. Clinical Course and Outcome of Human Monkeypox in Nigeria. Clinical Infectious Diseases. 2020; 71(8): E210–E214.
    DOI  |   Google Scholar
  15. Centers for Disease Control and Prevention. Treatment information for healthcare professionals. Centers for Disease Control and Prevention. [Internet] 2022 [cited 2022 June 18] Available from: https://www.cdc.gov/poxvirus/monkeypox/clinicians/treatment.html
     Google Scholar
  16. Fleischauer AT, Kile JC, Davidson M, Fischer M, Karem KL, Teclaw R, et al. Evaluation of human-to-human transmission of monkeypox from infected patients to health care workers. Clinical Infectious Diseases. 2005; 40(5): 689–694.
    DOI  |   Google Scholar
  17. Centers for Disease Control and Prevention. Update: multistate outbreak of monkeypox--Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR. Morbidity and Mortality Weekly Report, 2003; 52(27): 642–646.
     Google Scholar
  18. Reynolds MG, Davidson WB, Curns AT, Conover CS, Huhn G, Davis JP, et al. Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerging Infectious Diseases. 2007; 13(9): 1332–1339.
    DOI  |   Google Scholar
  19. Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. International Journal of Epidemiology. 1988; 17(3): 643–650.
    DOI  |   Google Scholar
  20. Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: A review of the past six years. British Medical Bulletin. 1988; 54(3): 693–702.
    DOI  |   Google Scholar
  21. Breman JG, Ruti K, Steniowski MV. Human monkeypox, 1970-79. Bulletin of the World Health Organization. 1980; 58(2): 165–182.
     Google Scholar
  22. Kabuga AI, El Zowalaty ME. A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria. Journal of Medical Virology. 2019; 91(4): 533–540.
    DOI  |   Google Scholar
  23. Erez N, Achdout H, Milrot E, Schwartz Y, Wiener-Well Y, Paran N, et al. Diagnosis of imported monkeypox, Israel, 2018. Emerging Infectious Diseases. 2019; 25(5): 980–983.
    DOI  |   Google Scholar
  24. Vaughan A, Aarons E, Astbury J, Balasegaram S, Beadsworth M, Beck CR, et al. Two cases of monkeypox imported to the United Kingdom, September 2018. Eurosurveillance. 2018; 23(38).
    DOI  |   Google Scholar
  25. Yong SEF, Ng OT, Ho ZJM, Mak TM, Marimuthu K, Vasoo S, et al. Imported monkeypox, Singapore. Emerging Infectious Diseases. 2020; 26(8): 1826–1830.
    DOI  |   Google Scholar
  26. Vaughan A, Aarons E, Astbury J, Brooks T, Chand M, Flegg P, et al. Human-to-human transmission of monkeypox virus, United Kingdom, October 2018. Emerging Infectious Diseases. 2020; 26(4): 782–785.
    DOI  |   Google Scholar